Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00541489 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A Phase 3 study, sponsored by NicOx.
- Completed
- Registry status
- Phase 3
- Development phase
- 800
- Enrollment target
NCT00541489 is a Phase 3 study that has completed, run by NicOx. The registered enrollment target is 800 participants.
The verdict
NCT00541489, a Phase 3 study, has completed, sponsored by NicOx.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 800 participants
- Enrollment target
Study Summary
To study the efficacy and safety of Naproxcinod vs. Placebo and Naproxen in the treatment of signs and symptoms of Osteoarthritis.
Interventions
- DRUG Placebo
- DRUG Naproxen
- DRUG Naproxcinod
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2007-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00541489
The ClinicalTrials.gov registry entry for NCT00541489 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NicOx, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00541489 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00541489 about?
NCT00541489 is a clinical study titled "Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip". To study the efficacy and safety of Naproxcinod vs. Placebo and Naproxen in the treatment of signs and symptoms of Osteoarthritis.
What is the current status of trial NCT00541489?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 800 participants. The study started on 2007-06.
What interventions are being tested in trial NCT00541489?
The interventions under investigation include: Placebo (DRUG), Naproxen (DRUG), Naproxcinod (DRUG).
Who is sponsoring clinical trial NCT00541489?
This trial is sponsored by NicOx, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.